Endologix (ELGX), TriVascular (TRIV) Enter Merger Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St up after tech selloff as yields retreat; Moderna surges
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
BMO Capital Downgrades Endologix (ELGX) to Market Perform
October 27, 2015 7:09 AM EDTBMO Capital downgraded Endologix (NASDAQ: ELGX) from Outperform to Market Perform with a price target of $12.00 (from $16.00).
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $13.73 yesterday.
... MoreTriVascular Technologies (TRIV) Prelim. Q3 Revenue Tops Estomates
October 26, 2015 4:05 PM EDTTriVascular Technologies (NASDAQ: TRIV) reported preliminary unaudited financial results for the third quarter ended September 30, 2015.
Preliminary revenue for the third quarter of 2015 is expected to be approximately $9.5 million, reflecting growth of 20% over the third quarter of 2014 on a reported basis and 23% on a... More
Endologix (ELGX) Tops Q3 EPS by 1c
October 26, 2015 4:03 PM EDTEndologix (NASDAQ: ELGX) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $38.12 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
... More